secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2024-08-23T23:59:59+00:00
Accession:  0001493152-24-033762
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies CFO resigns; J. Michael Edwards named interim CFO
--------------------------------------------------------------------------

- CFO Michael Dougherty resigns effective Sept. 16, 2024; no disagreement with company.
- J. Michael Edwards appointed interim CFO effective Sept. 16, 2024; served as CFO from 2014 to 2023 and led 2022 IPO.
- Edwards receives $10,000/month salary plus expenses under consulting agreement; company will search for permanent CFO.
- Dougherty will assist transition through Sept. 15, 2024; accepting CFO role in Pacific Northwest energy industry.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315224033762/0001493152-24-033762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315224033762/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer